Calmare Therapeutics Price History
CTTCDelisted Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Calmare Stock, it is important to understand the factors that can impact its price. As of today, the current price of Calmare Therapeutics stands at 0.0001, as last reported on the 18th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found eighteen technical indicators for Calmare Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Calmare Therapeutics' Risk Adjusted Performance of 0.2234, mean deviation of 165.8, and Standard Deviation of 290.29 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Calmare Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Calmare |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CTTC |
Based on monthly moving average Calmare Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Calmare Therapeutics by adding Calmare Therapeutics to a well-diversified portfolio.
Calmare Therapeutics Stock Price History Chart
There are several ways to analyze Calmare Stock price data. The simplest method is using a basic Calmare candlestick price chart, which shows Calmare Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Calmare Stock Price History Data
The price series of Calmare Therapeutics for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 has a statistical range of 0.0 with a coefficient of variation of 192.02. The prices are distributed with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company had 3:2 stock split on 17th of March 1981.Open | High | Low | Close | Volume | ||
12/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | ||
01/23/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 7,750 | |
01/06/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 160.00 | |
12/29/2022 | 0.0001 | 0.0002 | 0.0001 | 0.0002 | 11,000 | |
12/28/2022 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 22,200 | |
12/22/2022 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 3,000 | |
12/21/2022 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 9,900 | |
12/16/2022 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,000.00 | |
12/14/2022 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,550 | |
12/12/2022 | 0 | 0 | 0 | 0 | 500.00 | |
11/28/2022 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 5,300 |
About Calmare Therapeutics Stock history
Calmare Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Calmare is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Calmare Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Calmare Therapeutics stock prices may prove useful in developing a viable investing in Calmare Therapeutics
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut. Calmare Therapeutics operates under Medical Devices classification in the United States and is traded on NYSEMKT Exchange. It employs 7 people.
Calmare Therapeutics Stock Technical Analysis
Calmare Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Calmare Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Calmare Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Calmare Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Calmare to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.2234 | |||
Jensen Alpha | 86.69 | |||
Total Risk Alpha | 62.38 | |||
Treynor Ratio | (4.11) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |